Back

The impact of duration and control of type 1 diabetes mellitus on microvascular function is strongly modified by the gene for connexin 37.

27 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Coronary epicardial and microvascular physiology Diagnostic Methods ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Jan Pitha

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

6 More presentations in this session

Presentation thumbnail
In vivo validation of intra-coronary absolute flow measurements and comparison of reliability between different microvascular indices and the microvascular resistance reserve
Doctor L. Minten (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Microvascular Resistance Reserve assessed by bolus and continuous thermodilution.
Doctor E. Gallinoro (Rome, IT)
Abstract Slides Video
Presentation thumbnail
The integration of angio-IMR, QFR and FFR for the detection of ischemia
Doctor R. Jukema (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Increased arterial stiffness in patients with ischemia and no obstructive coronary artery disease
Mr A. Sakalidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
The impact of primary percutaneous coronary intervention strategies during st-elevation myocardial infarction on the prevalence of coronary microvascular dysfunction
Doctor A. Aldujeli (Co. Limerick, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary epicardial and microvascular physiology

The Event

Event poster

ESC Congress 2023

27 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Endotypes of coronary microvascular dysfunction in patients with and without Diabetes Mellitus
25 August 2023
thumbnail
Congress Presentation
Diabetes mellitus induces endothelial JAM-A upregulation, accelerating monocytic transmigration but not adhesion
1 September 2025
thumbnail
Congress Presentation
Diabetes Mellitus influence in Lipoprotein(a) gene expression and association to coronary artery disease
2 September 2024
thumbnail
Congress Presentation
Twelve-months treatment with dapagliflozin improves endothelial glycocalyx and cardiovascular function in patients with type 1 diabetes mellitus
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources